Both non-lean and lean individuals with metabolic dysfunction-associated steatotic liver disease are susceptible to long-term liver and cardiovascular disease outcomes, according to data presented at ...

CKD screening at age 55, combined with SGLT2 inhibitors, reduces kidney failure incidence and improves life expectancy across racial and ethnic groups. Non-Hispanic Black adults experience the most ...

The only example of a screening examination with a screen-detected cancer that would have been missed by AI in a hybrid reading strategy based on the AI uncertainty score of the entropy of the mean ...